Trial Details
RECRUITINGBasic Information
| Clinical ID | c680 |
|---|---|
| Identifier | NCT06227910 |
| Trial Title | A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Vedolizumab|DRUG: Upadacitinib|DRUG: Placebo |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | La Jolla |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-01-02 |
|---|---|
| Primary Completion Date | 2027-06-08 |
| Completion Date | 2028-08-01 |